HomeArticle

MegaRobo Technologies completes nearly USD 200 million financing to build AI intelligent infrastructure directly oriented to the real world | 36Kr Exclusive

胡香赟2026-11-19 08:30
Total accumulated financing has reached nearly USD 600 million.

By HU Xiangyun

Edited by HAI Ruojing

36Kr has learned that MegaRobo Technologies has recently completed a new round of financing of nearly 200 million USD. This round of financing is participated in by Oman Investment Authority (OIA), the sovereign wealth fund of the Sultanate of Oman, with additional investment from existing shareholders including Asia Investment Capital, Granite Asia and Sinovation Ventures, and follow-on investment from institutions such as CMB International, Suzhou Venture Capital and Sanjiang Investment Promotion Group, covering international sovereign capital, leading financial capital and local state-owned industrial capital.

At present, if AI for Science wants to achieve real large-scale implementation, it cannot avoid a fundamental issue: data. Large-scale, high-quality and reusable scientific research data is still a scarce resource, while the equipment and consumables in the vast majority of life science laboratories in China still do not have the ability to generate data on a large scale with consistent quality.

HUANG Yuqing, founder and CEO of MegaRobo, once described this as "the contradiction between the growing demand for data from scientists and the relatively backward productivity". It is precisely this contradiction that has pushed AI automated laboratories to usher in a new small peak amid this year's AI4S investment boom.

As artificial intelligence expands from the digital world to the physical world, data alone is not enough. It is necessary to promote AI to truly enter complex physical systems such as scientific research, laboratories and production lines, connect models, data, software, hardware and physical execution, and complete the whole process from thinking, design to execution, observation, continuous feedback learning and optimization.

Source: MegaRobo Technologies

In China, MegaRobo Technologies is one of the early companies that deployed in this direction. In the ten years since its establishment, MegaRobo Technologies has raised a total of nearly 600 million USD in financing. In June 2025, MegaRobo Technologies submitted its listing application to the Hong Kong Stock Exchange. According to the prospectus, as of June 2025, MegaRobo Technologies had 1.5 billion RMB in hand orders.

In the early days of its founding, the MegaRobo team once wanted to develop a general-purpose robot that could be deployed in millions of life science laboratories, but soon found that what scientists need is not a single device, but a complete set of solutions from experimental design to execution and data processing.

Therefore, the team turned to building a super laboratory from 2019. Its core carrier is the MegaRobo Kunpeng Lab, which is defined by the company as a "data factory for the life science industry". The 1.0 version of this project was put into operation in 2021, realizing 7×24 hour unmanned experiments, and it has now been iterated to the 4.0 version.

According to public information from MegaRobo Technologies, the biggest change of the iterated MegaRobo Kunpeng Lab is that it has shifted from "automated execution" to "autonomous agent-driven", positioning itself as a new-generation AI-native scientific discovery and verification platform built for AI for Science. The laboratory is split into two "brains": after receiving the target, the dry lab brain will automatically review literature and design experimental paths, and the wet lab brain is responsible for translating and issuing instructions. The scheduling agent in the middle directs the robotic arm to complete the transfer between devices, which can redesign scientific R&D into a closed loop of "AI design - autonomous experiment - real experiment verification - data generation - model learning".

Taking the recent operating data as an example, this platform completed the large-scale advancement of 31 drug R&D pipelines within 7 months.

On the business side, MegaRobo Technologies currently has two major segments: scientific intelligence and industrial intelligence. In terms of scientific intelligence, the company has delivered relevant infrastructure to more than 500 customers, covering multinational pharmaceutical companies, CROs, biotech companies and scientific research institutions, supporting links from early-stage scientific research, target exploration, drug screening to candidate optimization and production quality control; the MegaRobo Kunpeng Lab has provided scientific research services for more than 200 customers.

A case that has been mentioned many times is that relying on the MegaRobo Kunpeng Lab, an antibody drug R&D team completed 56 rounds of closed-loop iteration of dry and wet experiments for 18 targets in 4 months, which is equivalent to the workload of dozens of scientific researchers in 3 to 4 years under the traditional model.

Recently, MegaRobo Technologies also jointly launched the Poreva Open Global AI Protein Design Challenge with Tencent Cloud and Twist Bioscience, with no restrictions on models and technical routes. The wet experiment verification is undertaken by the MegaRobo Kunpeng Lab, which aims to establish an "open evaluation scale" for AI4S with a scale of more than 10,000 designed protein sequences.

In terms of industrial intelligence, it mainly focuses on manufacturing scenarios such as semiconductors, optical interconnection and new displays, providing capabilities including defect identification, quality control, yield analysis, anomaly diagnosis and process parameter optimization. The goal is not only to "find defects", but also to enable AI to gradually understand the complex correlations among materials, processes, equipment and yield.

At the same time, the company's business model is also evolving continuously, forming two types of delivery models: one is centered on intelligent infrastructure, providing products and platforms that integrate AI, software and hardware; the other is ARO (AI-Native Research Organization), which integrates AI capabilities with experimental execution to provide scientific research services for customers. The former outputs infrastructure and technical capabilities, while the latter further converts these capabilities into actual scientific research results, continuously generates high-quality feedback from the real world, and accelerates scientific discovery.

MegaRobo Technologies stated that after this round of financing, it will continue to increase investment in core technology R&D and global business, and strengthen cooperation in markets including China, Europe, North America, the Middle East and Southeast Asia. "In the past, the most important capability of AI was to learn from the knowledge accumulated by human beings. In the next stage, it will increasingly enter the real world, and help humans create new knowledge, new materials, new processes and new products through experiments, manufacturing and continuous feedback. What we hope to build is the infrastructure that enables this capability to occur on a large scale," said HUANG Yuqing.